IDEAYA Biosciences, Inc. IDYA

Updated: 11 Aug 2026

NASDAQ | Biotech | Precision medicine oncology

No signal published yet

We already track IDEAYA Biosciences and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow IDEAYA Biosciences free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Precision medicine oncology
We're already tracking IDEAYA Biosciences, Inc. — here are the latest events we've registered

Recent News

  • On August 4, 2026, IDEAYA Biosciences reported its second-quarter 2026 financial results, highlighting that its registrational Phase 2/3 OptimUM-02 trial evaluating darovasertib in metastatic uveal melanoma met its primary endpoint. The company is actively advancing its New Drug Application filing under the FDA's Real-Time Oncology Review program with completion targeted in H2 2026. IDEAYA ended the quarter with approximately 1.24 billion USD in cash, cash equivalents, and marketable securities.

What Firelda Watch includes for IDEAYA Biosciences, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of IDEAYA Biosciences, Inc. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Boozt AB (publ)
BOOZT
HOLD
Vitrolife AB (publ)
VITR
HOLD
Lagercrantz Group
LAGR B
NEUTRAL
Tetra Tech, Inc.
TTEK
HOLD
Vicore Pharma Holding AB (publ)
VICO
HOLD

Biotech

More companies in this sector

Want to follow IDEAYA Biosciences, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow IDEAYA Biosciences free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

IDEAYA Biosciences, Inc. IDYA
IDEAYA Biosciences — follow and we'll monitor it
Follow IDEAYA Biosciences free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.